BT Thompson, CR Spence, SP Janssens, PM Joseph and CA Hales
Pulmonary/Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

Heparin inhibits smooth-muscle cell (SMC) growth in vitro and inhibits the development of hypoxic pulmonary hypertension and vascular remodeling in vivo. We wondered whether preparations of heparin with different antiproliferative potency in vitro would differ in their ability to inhibit the development of hypoxic pulmonary hypertension in vivo. Two such heparins, a weakly antiproliferative lot of Elkins-Sinn (E-S) (% inhibition of SMC growth at 10 micrograms/ml = 13 +/- 9% [mean +/- SEM, n = 24]) and a more active lot from Upjohn (UJ) (% inhibition = 71 +/- 12% [n = 12, p < 0.05 versus E-S]), were infused subcutaneously (300 U.S.P. units/day; E-S 300 versus UJ 300) via an osmotic pump into guinea pigs exposed to hypoxia (10% O2) for 10 d, after which pulmonary artery pressure (PAP; mm Hg) and cardiac index (CI; ml/min/kg) were measured in room air. Hypoxic controls (HC) received saline. PAP increased from 11 +/- 1 mm Hg in normoxic controls (NC) (n = 5) to 24 +/- 1 mm Hg in HC (n = 8, p < 0.05). The PAP was lower in the E-S 300 (21 +/- 1; n = 7, p < 0.05 versus HC and NC) and even lower in the UJ 300-treated group (18 +/- 0.5; n = 7, p < 0.05 versus HC and NC). Total pulmonary vascular resistance (TPR; mm Hg/ml/min/kg) increased significantly from 0.038 +/- 0.002 in NC to 0.076 +/- 0.003 (p < 0.05) in HC. There was no difference in TPR between the HC and the E-S 300-treated group.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				E. Al-Ansari, H.-k. Du, L. Yu, C. D. Ochoa, H. G. Garg, D. A. Quinn, and C. A. Hales Low-Molecular-Weight Heparin Inhibits Hypoxic Pulmonary Hypertension and Vascular Remodeling in Guinea Pigs Chest, December 1, 2007; 132(6): 1898 - 1905. [Abstract] [Full Text] [PDF]

				L. Yu, D. A. Quinn, H. G. Garg, and C. A. Hales Cyclin-Dependent Kinase Inhibitor p27Kip1, But Not p21WAF1/Cip1, Is Required for Inhibition of Hypoxia-Induced Pulmonary Hypertension and Remodeling by Heparin in Mice Circ. Res., October 28, 2005; 97(9): 937 - 945. [Abstract] [Full Text] [PDF]

				A. Widlitz and R.J. Barst Pulmonary arterial hypertension in children Eur. Respir. J., January 1, 2003; 21(1): 155 - 176. [Abstract] [Full Text] [PDF]

				E. Papakonstantinou, M. Roth, M. Tamm, O. Eickelberg, A. P. Perruchoud, and G. Karakiulakis Hypoxia Differentially Enhances the Effects of Transforming Growth Factor-beta Isoforms on the Synthesis and Secretion of Glycosaminoglycans by Human Lung Fibroblasts J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 830 - 837. [Abstract] [Full Text] [PDF]

				H. G. Garg, B. T. Thompson, and C. A. Hales Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L779 - L789. [Abstract] [Full Text] [PDF]

				E. Papakonstantinou, G. Karakiulakis, M. Tamm, A. P. Perruchoud, and M. Roth Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L825 - L834. [Abstract] [Full Text] [PDF]

				J. Khoury and D. Langleben Heparin-like molecules inhibit pulmonary vascular pericyte proliferation in vitro Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L252 - L261. [Abstract] [Full Text] [PDF]

				J. K. Belknap, M. C. M. Weiser-Evans, S. S. Grieshaber, R. A. Majack, and K. R. Stenmark Relationship between Perlecan and Tropoelastin Gene Expression and Cell Replication in the Developing Rat Pulmonary Vasculature Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 24 - 34. [Abstract] [Full Text]

				S.-L. Lee, W.-W. Wang, P. M. Joseph, C. A. Hales, and B. L. Fanburg Inhibitory Effect of Heparin on Serotonin-induced Hyperplasia and Hypertrophy of Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 78 - 83. [Abstract] [Full Text]

				A. Fryer, Y.-C. Huang, G. Rao, D. Jacoby, E. Mancilla, R. Whorton, C. A. Piantadosi, T. Kennedy, and J. Hoidal Selective O-Desulfation Produces Nonanticoagulant Heparin that Retains Pharmacological Activity in the Lung, J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 208 - 219. [Abstract] [Full Text]

				D. J. Horstman, L. G. Fischer, P. C. Kouretas, R. L. Hannan, and G. F. Rich Role of nitric oxide in heparin-induced attenuation of hypoxic pulmonary vascular remodeling J Appl Physiol, May 1, 2002; 92(5): 2012 - 2018. [Abstract] [Full Text] [PDF]